National Doctor’s day is celebrated on July 1st every year in India, and Navitas Life Sciences would like to express our gratitude to the exceptional physicians who tirelessly contribute to the well-being of patients. At Navitas Life Sciences, we recognize the invaluable role doctors play not only in patient care but also in advancing clinical research. In this blog, we highlight how doctors support clinical research and showcase the capabilities of Navitas Life Sciences in enabling our efficient clinical trials, aiding in bringing life saving medicines to patients who most need them.
I chose to be a part of clinical research to drive advancements in medicine, shape the future of healthcare, and make a lasting impact on the lives of countless patients. I look forward to working diligently and passionately with my fellow doctors and clinical researchers as we strive to bring new treatments and hope to those in need. I wish my fellow physicians a Happy Doctor's Day dedicated to improving lives through the pursuit of knowledge and healing.”

Vice President
Medical Services and Client Solutions
Strategic Partner for Full-Service Clinical Trials:

Navitas Life Sciences offers comprehensive support for clinical trials, and doctors play a vital role in this process. Our expert team collaborates closely with physicians to design robust study protocols, ensuring scientific integrity and ethical compliance. Doctors serve as principal investigators or co-investigators, leading the implementation of trials, overseeing patient recruitment, and ensuring patient safety throughout the study. Their deep clinical knowledge and patient-centric approach are instrumental in the successful execution of clinical trials.

Navitas Life Sciences leverages its domain expertise, technology knowledge, and world-class systems & processes to support the entire spectrum of clinical trial needs. Our end-to-end clinical trials operations provides support with Clinical program management, feasibility, site selection and activation, Site management and clinical monitoring (including Risk Based Monitoring (RBM), Central Monitoring (CM), Remote Monitoring (RM) & Adaptive monitoring).

Associate Director
Medical and Scientific Affairs
Stellar Pharmacovigilance Support: 30+ Years of Safety Monitoring
Pharmacovigilance, the science of monitoring and assessing the safety of medications, requires the services of doctors, among others. It contributes to the identification, documentation, and evaluation of adverse drug reactions and other drug-related safety concerns.
Patient safety has always been a critical concern and it is a critical component in core processes for Life Sciences companies. Hence, drug safety departments are increasingly focusing on core activities, to contribute their insights throughout the product lifecycle to ensure better risk management and effective market interventions.
We leverage technology to automate processes, use data to drive insights and hence, improve efficiencies while supporting the safety profile of drugs.

Your Partner for Pharmacovigilance
Navitas Life Sciences is a full-service Pharmacovigilance provider, offering Services along the PV Value chain right from Case Intake to Safety Risk Management. With operating centers in Germany and India, Navitas provides a combination of offshore and onshore teams that can reliably serve the entire PV spectrum.

From the clinic to Navitas Life Sciences
“It seems to be common knowledge: if you study medicine, you will work as doctor in a hospital. But I decided to go into the world of pharmaceutical medicine to work with such a diversity of people with the most diverse academic backgrounds. Here I can contribute to the success of products and projects based on my medical pharmacovigilance expertise.”
Director
Pharmacovigilance & QPPV
Regulatory Support:
Navigating the complex regulatory landscape is crucial for successful clinical research, and collaborating with our regulatory affairs experts will ensure compliance with local and international regulations, guidelines, and ethical standards.

Doctors provide critical insights into clinical trial submissions streamlining the path to approvals and expediting study timelines.
Industry-Leading Networks:
Navitas Life Sciences is proud to have built strong networks with peers across the life sciences and pharma sectors worldwide. These networks foster collaboration, allowing for seamless access Our networks community is the place to discuss trends, insights, and future solutions.
Our industry leading networks are an independent sounding board to test and validate the latest thinking, and uncover industry insights to develop compelling, yet pragmatic strategies to provide business value and meet the needs of patients, payers, and prescribers.
The latest addition to our Industry leadingnetworks is medtechnet, a cross-network collaboration that is expected to revolutionize device safety processes and organizations. Built upon core principles of strategic thinking and peer exchange, medtechnet provides a neutral platform for Heads and expert practitioners in Safety, Regulatory, Labeling, and Quality across the pharmaceutical and medical technology sectors. With a focus on deploying Safety, Vigilance, and Regulatory strategy within organizations, medtechnet empowers members to collaborate and influence the future of NextGen Device and Combination Product safety.

PV and MedTech Networks Thought Lead
On this Doctor's Day, we commend the efforts of doctors in healthcare and in clinical research, in doing so, driving advancements in healthcare. Navitas Life Sciences is committed to supporting doctors in their pursuit of improving patient outcomes and contributing to medical knowledge.
Our capabilities in full-service clinical trials, pharmacovigilance, regulatory support, and our industry-leading networks ensure transformative support for bringing advancements in medical to the market faster and efficiently. Together, we can continue to push the boundaries of medical innovation, ultimately benefiting patients worldwide.
Novel approaches in early phase Oncology trials to revolutionize Cancer care
Read the insightful by Sowmya Kaur, Dr Atul Gupta, and Dr Akash Gadgade to find out how the pursuit for effective treatment modalities for cancer rides on sustained efforts with catalyzed adoption of technological advancements that surpass traditional paradigms.
Published by PharmaFocus Asia
March 2023 | Issue 50 | Pages 44 - 47

To know more about our service and solutions, reach out to us at